Wolfgang Sievert1, Stefan Stangl2, Katja Steiger3, Gabriele Multhoff4. 1. Center of Translational Cancer Research, Technische Universität München (TranslaTUM), Campus Klinikum rechts der Isar, Department of Radiation Oncology, Klinikum rechts der Isar, Munich, Germany. Electronic address: wolfgang.sievert@tum.de. 2. Center of Translational Cancer Research, Technische Universität München (TranslaTUM), Campus Klinikum rechts der Isar, Department of Radiation Oncology, Klinikum rechts der Isar, Munich, Germany. 3. Institute of Innovative Radiotherapy, Helmholtz Zentrum München, Munich, Germany. 4. Center of Translational Cancer Research, Technische Universität München (TranslaTUM), Campus Klinikum rechts der Isar, Department of Radiation Oncology, Klinikum rechts der Isar, Munich, Germany; Institute of Pathology, Technische Universität München, Munich, Germany.
Abstract
PURPOSE: The aim was to reduce radiation exposure of the lung in experimental models to increase overall survival of mice to study late radiation-induced heart disease. METHODS AND MATERIALS: A new irradiation plan was established on the Small Animal Radiation Research Platform machine for local heart irradiation of mice with single doses of 8 and 16 Gy. Lung damage was analyzed 20, 30, 40, and 50 weeks after irradiation by computed tomography scans and histology and compared with a sham-irradiated, age-matched, control group. RESULTS: The use of an 8 × 6-mm2 collimator enabled local heart irradiation whereby only 18% of the lung received any irradiation. The V10 and V16 of the lung were 14% and 7%, respectively. After a mean heart dose of 8 and 16 Gy, mice survived for at least 50 weeks after irradiation. Computed tomography images demonstrated increased cell densities in the irradiated lung volume 50 weeks after irradiation. Concomitantly, histologic examination revealed fibrotic and inflammatory changes in the irradiated lung volume. In the heart, amyloid depositions and left ventricle hypertrophy were observed. CONCLUSIONS: High-precision heart irradiation with 8 and 16 Gy using an 8 × 6-mm2 beam induced cardiac amyloidosis and hypertrophy, which did not lead to myocardial dysfunction despite the presence of radiation pneumopathy in the small V16 of the exposed lung. By using the improved irradiation plan (V16: 7%), long-term survival of the mice after heart irradiation can be achieved that allows clinically relevant experimental investigation of late radiation-induced heart disease effects.
PURPOSE: The aim was to reduce radiation exposure of the lung in experimental models to increase overall survival of mice to study late radiation-induced heart disease. METHODS AND MATERIALS: A new irradiation plan was established on the Small Animal Radiation Research Platform machine for local heart irradiation of mice with single doses of 8 and 16 Gy. Lung damage was analyzed 20, 30, 40, and 50 weeks after irradiation by computed tomography scans and histology and compared with a sham-irradiated, age-matched, control group. RESULTS: The use of an 8 × 6-mm2 collimator enabled local heart irradiation whereby only 18% of the lung received any irradiation. The V10 and V16 of the lung were 14% and 7%, respectively. After a mean heart dose of 8 and 16 Gy, mice survived for at least 50 weeks after irradiation. Computed tomography images demonstrated increased cell densities in the irradiated lung volume 50 weeks after irradiation. Concomitantly, histologic examination revealed fibrotic and inflammatory changes in the irradiated lung volume. In the heart, amyloid depositions and left ventricle hypertrophy were observed. CONCLUSIONS: High-precision heart irradiation with 8 and 16 Gy using an 8 × 6-mm2 beam induced cardiac amyloidosis and hypertrophy, which did not lead to myocardial dysfunction despite the presence of radiation pneumopathy in the small V16 of the exposed lung. By using the improved irradiation plan (V16: 7%), long-term survival of the mice after heart irradiation can be achieved that allows clinically relevant experimental investigation of late radiation-induced heart disease effects.
Authors: Mihaela Ghita; Victoria Dunne; Gerard G Hanna; Kevin M Prise; Jaqueline P Williams; Karl T Butterworth Journal: Br J Radiol Date: 2019-02-13 Impact factor: 3.039
Authors: Zijian Deng; Xiangkun Xu; Tomas Garzon-Muvdi; Yuanxuan Xia; Eileen Kim; Zineb Belcaid; Andrew Luksik; Russell Maxwell; John Choi; Hailun Wang; Jingjing Yu; Iulian Iordachita; Michael Lim; John W Wong; Ken Kang-Hsin Wang Journal: Int J Radiat Oncol Biol Phys Date: 2019-11-15 Impact factor: 7.038
Authors: Raimund H M Preidl; Patrick Möbius; Manuel Weber; Kerstin Amann; Friedrich W Neukam; Marco Kesting; Carol-Immanuel Geppert; Falk Wehrhan Journal: Strahlenther Onkol Date: 2018-10-15 Impact factor: 3.621
Authors: Ioannis I Verginadis; Constantinos Koumenis; Alexandra D Dreyfuss; Denisa Goia; Khayrullo Shoniyozov; Swapnil V Shewale; Anastasia Velalopoulou; Susan Mazzoni; Harris Avgousti; Scott D Metzler; Paco E Bravo; Steven J Feigenberg; Bonnie Ky Journal: Clin Cancer Res Date: 2021-02-04 Impact factor: 13.801
Authors: Omid Azimzadeh; Christine von Toerne; Vikram Subramanian; Wolfgang Sievert; Gabriele Multhoff; Michael J Atkinson; Soile Tapio Journal: Front Public Health Date: 2021-07-02